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Abstract 
The BONEBRIDGE bone-conduction device is used to treat conductive and mixed hearing 
losses. The size of its floating mass transducer (FMT) can preclude implantation in certain 
anatomies, necessitating comprehensive surgical planning. Current techniques are time 
consuming and difficult to transfer to the operating room. The objective of this thesis was to 
develop software for calculating skull thickness to the dura mater to find locations for the 
FMT and to the first air cells which guarantee sufficient bone for the implant screws to grasp. 
Temporal bone computed tomography (CT) images were segmented and processed and 
custom Matlab code was written to generate and test thickness colormaps. For validation, 
measurements performed by a trained otologist were compared to the algorithm estimations 
achieving sub-millimeter accuracy. Results suggest this software can be used in the surgical 
workflow to automate thickness estimation and aid in finding an ideal location for the 
BONEBRIDGE device and screws. 
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Chapter 1  
Introduction 
 
1.1 Overview 
In this thesis, patient data were analyzed for bone conduction implant surgery, an implant 
designed to alleviate hearing loss. A method was then developed to automate a part of the 
surgical planning procedure, with the goal of saving clinical time. This introductory 
chapter begins with a short review on the anatomy and physiology of the ear, followed by 
an explanation of the degrees and types of hearing loss, current bone conduction devices, 
and lastly summarizes the image processing approaches adopted in this research.  
1.2 The Human Hearing System 
The human ear is divided into three sections. External, middle and internal. An overview 
of the human ear anatomy can be observed in Figure 1-1.  
 
Figure 1-1: Coronal cross-section of ear anatomy.  Image courtesy of Stanford 
University School of Medicine [1]  
2 
 
The external ear is formed by the auricle and ear canal. It receives sound waves travelling 
through the air in the ear canal and conducts them into the middle ear.  
The middle ear consists of the tympanic membrane and the internal bones that form the 
ossicular chain (incus, malleus and stapes). The sound waves in the ear canal vibrate the 
tympanic membrane, which in turn triggers the ossicular chain that sends the mechanical 
vibrations into the inner ear. 
The inner ear consists of both the vestibular system, which is related to balance, and the 
cochlea and auditory nerve, which are related to hearing. Inside the cochlea, hair cells 
convert the received vibrations into electrical impulses of different frequencies that are 
then sent to the brain via the auditory nerve. Figure 1-2 depicts the main components of 
the middle and inner ears.   
 
Figure 1-2: Middle and inner ear anatomy.  Image courtesy of Stanford University 
School of Medicine [1] 
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1.3 The Temporal Bone 
The human skull has two temporal bones, one on either side of the skull as shown in 
Figure 1-3a.  
 
Figure 1-3: Location of the temporal bone in the skull (a) from [2] and its 
components (b) from [1] 
Each temporal bone is divided into several main sections that can be observed in Figure 
1-3b. The petromastoid is a combination of the petrous and the mastoid sections of the 
temporal bone, and contains the essential organs required for hearing. The fissure 
between the petromastoid and tympanic sections leads into the middle ear, or tympanic 
cavity. The tympanic cavity houses the external acoustic meatus (ear canal). The 
zygomatic process contains the junction where the squamous section and the mandible 
meet. The styloid process serves as an anchor point for several muscles associated with 
the tongue and larynx. The squamous section is formed by thin bone and forms the lateral 
wall of the middle cranial fossa. The squamous section overlaps superiorly with the 
parietal bone, which occupies the largest space of the top and side of the head. The 
parietal bone is delineated in Figure 1-4. 
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Figure 1-4: Location of the two parietal bones (red) in the skull.  (a) Frontal and (b) 
lateral views from [3] 
1.4 Hearing Loss 
Hearing loss is a global public health concern recognized by the World Health 
Organization (WHO). It is the second impairment, after anemia, that affects the greatest 
number of people around the globe [4]. Approximately 1.33 billion people endure hearing 
loss [4], of which 473 million people suffer from disabling hearing loss [5], making up 
5% of the worldwide population. There are currently 34 million children suffering from 
disabling hearing loss where language skills and educational development require special 
attention and are often delayed if the impairment is left unattended, even when hearing 
loss is unilateral [6]. According to the WHO, 60% of childhood hearing loss is 
preventable through public health strategies that deal with infections, birth complications 
and treatment of expectant mothers [7, 8]. In elderly adults (over 65 years), one in every 
three have disabling hearing loss, which can contribute to dementia and cognitive decline 
when untreated [7]. Approximately 19% of the Canadian population from ages 20 to 79 
currently suffer from hearing loss [9], and a billion young people worldwide are at risk of 
permanent damage due to their listening habits [10]. Hearing loss is also more likely in 
households with low income and/or low educational attainment [9]. Hearing loss has a 
worldwide economic impact of 750 billion US dollars annually, with costs associated to 
healthcare, educational support and productivity losses [4, 7]. If causes of irreversible and 
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disabling hearing loss, like with chronic ear infections, occupational noise and ototoxic 
medications are left unattended, the global statistic could rise to 630 million people by 
2030 and to 900 million in 2050 [7], doubling the current occurrence up to 10% of the 
population. To prevent this, the WHO recommends early identification of the issue to 
prompt the use of hearing aids or implants to improve quality of life. It is estimated that 
72 million people could potentially benefit from a hearing device [7], adding to the 
challenge of supplying sufficient access to physicians. 
1.4.1 Types and Degrees of Hearing Loss 
Hearing loss can be classified by type and degree. There are three main types of hearing 
loss. Conductive hearing loss (CHL) is the reduction of sound transmission in the middle 
or outer ear. CHL can be caused by a damaged or perforated tympanic membrane; 
abnormalities preventing the proper movement of the ossicular chain, such as fixed 
malleus syndrome [11]; or pathologies, such as otitis media or middle ear malformations 
[12] in the aforementioned structures; among other causes. Sensorineural hearing loss 
(SNHL) is caused by abnormalities in the inner ear, where speech recognition is often 
decreased. Mixed hearing loss (MHL) is a combination of problems in the outer, middle 
and inner ears, and shares elements from CHL and SNHL. Table 1-1 presents degrees of 
hearing loss in accordance with the American Speech-Language-Hearing Association; 
values are in decibels of hearing loss (dB HL) which measures the degree of hearing loss 
in relation to the standard of normal hearing. 
Table 1-1: Hearing loss categorized by the degree of loss  [13]  
Hearing Loss Degree 
 
Hearing Loss Range 
(dB HL) 
Normal Up to 15 
Slight 16-25 
Mild 26-40 
 Moderate 41-55 
Moderately Severe  56-70 
Severe 71-90 
Profound >91 
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1.4.2 Treatment of Hearing Loss 
Various treatment options are available depending on the type (conductive, sensorineural, 
or mixed) and degree of hearing loss. Patients with mild to moderate hearing loss, 
regardless of type, can largely benefit from wearing hearing aids. Hearing aids deliver 
amplified sound into the ear and do not require surgery.  
Severe to profound hearing loss is most commonly sensorineural, and can be treated with 
a cochlear implant, which involves an electrode that is surgically implanted into a 
patient’s cochlea. Cochlear implants deliver electrical impulses to the cochlear nerve, 
bypassing the outer and middle ear, in order to allow the patient to hear an array of 
frequencies that permit the interpretation of speech.  
Conductive and mild MHL are typically treated with hearing aids.  However, many 
patients cannot wear hearing aids due to previous surgery, recurrent infections, or atresia 
(where the external auditory canal and/or pinna are congenitally malformed). These 
patients can be treated with a bone conduction device (BCD), which bypass the external 
auditory canal and middle ear by transmitting sound vibrations through the temporal bone 
into the cochlea.  
1.5 Bone Conduction Devices 
Bone conduction is the transmission of sound through the bones of the skull, it occurs 
when the vibrations representing sound that normally happen in the middle ear take place 
in the skull instead. These vibrations compress and expand the skull forcing the 
movement of the fluids in the cochlea. The intensity of the transmission depends on the 
incoming sound frequency and bone structure [14]. 
BCDs are embedded in the temporal bone and convert sound into vibrations in the skull, 
which are picked up by the cochlea and then sent to the brain, therefore bypassing the 
middle and outer ears to produce the sensation of hearing. BCDs are a recommended 
treatment for patients with CHL or MHL that do not attain sufficient audiological 
improvement from, or are unable to wear, conventional hearing aids. This can be caused 
by a number of reasons including occlusion of the outer ear canal, recurrent infections, or 
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persistent drainage [15, 16]. BCDs are the only option to treat CHL when it is 
accompanied by bony atresia or intractable drainage [15]. 
Percutaneous devices were the first type of BCD developed during the 1970s out the 
necessity to improve on the discomforts of conventional hearing aids, such as auditory 
feedback and pressure [14]. The most commonly used device of this category is the 
Bone-Anchored Hearing Aid (BAHA), introduced in Sweden in the late 1970s [17]. The 
BAHA stimulates the temporal bone via an osseointegrated (adhered to bone) screw 
made of titanium and an abutment through the skin (percutaneous) connected to the 
external unit. After no longer being able to wear conventional hearing aids, patients have 
reported improvement in speech recognition, sound quality, and comfort with the BAHA 
[18]. Even though the complication rate for the BAHA is low, the percutaneous abutment 
and the interface with the titanium screw can represent risk of recurring infection, skin 
overgrowth, or wound dehiscence [16].   
Passive transcutaneous BCDs avoid the issues related to the percutaneous nature of the 
BAHA by stimulating a magnet implanted transcutaneously through an external 
stimulator, vibrating the bone through the skin instead of directly. However, it has been 
reported that in comparison with the BAHA, the hearing improvement at higher 
frequencies is considerably lower, and the vibration in the soft tissue may cause a variety 
of skin problems such as swelling or infection after fitting [19]. A transcutaneous version 
of the BAHA was introduced in 2013 [20]. 
In active transcutaneous BCDs, vibrations are transmitted directly to the temporal bone 
via a floating mass transducer (FMT) that converts sound into vibrations. This active 
component is implanted in the bone under the skin. In contrast with the percutaneous 
BAHA, the electrical signal from the processor is transmitted through the skin instead of 
through mechanical vibrations [19]. Active transcutaneous BCDs have fewer 
complications than percutaneous and passive BCDs, but they can be surgically 
challenging to insert [19]. 
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1.6 The BONEBRIDGE 
The BONEBRIDGE is a partially implantable, active transcutaneous BCD developed by 
MED-EL (Innsbruck, Austria) that was first implanted in June 2011 as part of a clinical 
trial and was launched onto the European market in September 2012. The first 
BONEBRIDGE implant in North America was performed at London Health Sciences 
Centre in April, 2013 [21, 22].  
The device consists of a floating mass transducer (FMT) surgically implanted into the 
temporal bone, which is powered trancutaneously by a transmitter coil [16, 23] and a 
digital audio processor that is magnetically held in place by the aforementioned coil 
beneath the skin [24]. In addition to CHL and MHL, the BONEBRIDGE can in some 
cases treat severe-to-profound SNHL in one ear, also known as Single Sided Deafness 
(SSD) if the contralateral ear has normal hearing. The BONEBRIDGE device is 
displayed in Figure 1-5.  
 
Figure 1-5: The BONEBRIDGE, its components and dimensions.  Image courtesy of 
MED-EL [25] 
As opposed to the BAHA, the two screws securing the device in the temporal bone do not 
need to be osseointegrated, therefore the BONEBRIDGE can be activated 
approximatively three weeks after implantation surgery [24]. Furthermore, 
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osseointegration of screws with the BAHA have been shown to fail in some pediatric 
cases [26].  
The BONEBRIDGE is indicated for patients who are aged 5 years and above, have 
conductive or mixed mild-to-moderate hearing loss and can still benefit from sound 
amplification. The main audiological requirement is that the pure tone average (PTA) 
bone conduction (BC) threshold measured at 0.5, 1, 2, 3 and 4 kHz should be better than 
or equal to 45 dB of hearing loss per ear. PTA refers to the average hearing threshold of a 
given set of frequencies. This parameter helps determine the degree of residual hearing 
the patient has and their capacity to interpret speech. 
Individuals with any of the following conditions in their medical history may benefit 
from the BONEBRIDGE, being that they are unable to wear conventional hearing aids: 
revision tympanoplasty, ear canal stenosis or chronically draining ears, otosclerosis or 
tympanosclerosis that cannot be rectified by surgery, or congenital malformations where 
ear canals are absent and cannot be restored through conventional surgery. The screening 
process to determine candidacy for the BONEBRIDGE also involves checking for 
sudden deafness, acoustic neuroma, or other conditions which cause severe to profound 
sensorineural hearing loss on one side [14].  
The BONEBRIDGE was developed to improve the audiological outcomes associated 
with passive transcutaneous BCDs and to reduce the complications associated with 
percutaneous BCDs. A recent systematic review of 29 studies, of which 12 studied safety, 
found that implant-related complications occurred in only 6 out of 117 patients, where 
minor adverse events such as headaches and wound pain were experienced and only one 
case required superficial revision surgery [14]. Other events included postoperative 
wound pain and dizziness, temporary tinnitus, headache, vertigo, seroma, and skin 
infection. Another study by Lassaletta et al. evaluated 27 postoperative BONEBRIDGE 
patients using pain questionnaires and found no significant postoperative pain 
irrespective of the sigmoid sinus (venous channels to the brain) or dural compression 
(external layer of the brain), and postoperative pain scores were similar to those 
experienced by patients with other transcutaneous auditory implants [27].  
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1.6.1 Implant Surgery 
The implant surgery for the BONEBRIDGE consists of drilling a bed in the temporal 
bone which allows for the placement of the FMT in accordance with the implant’s 
dimensions. There are currently three surgical approaches described in the literature and 
each is performed depending on a patient’s specific anatomy. The transmastoid approach 
is the most common approach for cases with previous middle ear surgeries with normal 
anatomy and is dependent on the volume of the mastoid. The venous sinuses and the dura 
mater are least likely to be compromised in this approach. The retrosigmoid approach is 
indicated for patients with difficult mastoid anatomy and is ideal for patients who have 
undergone previous mastoidectomy for chronic otitis media. However, the bone in this 
region is often curved, and surgery requires dissection of the nuchal musculature. The 
middle fossa approach may also be used as an alternative to the transmastoid approach.  
In this approach, the incision is located above the ear in the squamous temporal bone and 
is approximately 3 cm in length (comparatively smaller than in the other two 
approaches), and cosmetically hidden in the hairline. Since the bone in this area can be 
thin, dura may be exposed; however there is minimal risk or sequelae [28, 29].  
Approximate locations for the mentioned approaches are displayed in Figure 1-6.  
 
Figure 1-6: Locations for BONEBRIDGE implant.  Mastoid (MS), retrosigmoid 
(RS) and middle fossa (MF) 
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In difficult cases, compression of the sigmoid sinus or dura can appear unavoidable, but it 
can be minimized by using BCI lifts. The BCI lifts are washers ranging in size from 1 to 
4 mm and can be attached to the BONEBRIDGE FMT to allow it to fit difficult 
anatomies [14]. Figure 1-7 showcases the BCI lifts.  
 
Figure 1-7: The BCI lifts , from 1 to 4 mm in size, aid in the implantation of the 
BONEBRIDGE in difficult anatomies. Image courtesy of MED-EL [25] 
1.6.2 Computed Tomography 
Computed tomography (CT) is an imaging modality capable of generating cross-sectional 
images (slices) by using X-rays taken from different angles of the target anatomy. CT 
images are displayed in grayscale representing the intensity of the light absorbed by the 
observed tissue. Head CT scans are typically used to detect head injury, where the darker 
structures indicate less tissue density and brighter structures indicate denser tissue. A 
head CT scan is employed in determining if a patient’s anatomy is appropriate for the 
placement of the BONEBRIDGE implant. CT allows for good visualization of 
anatomical landmarks relevant to the implant surgery, such as the sigmoid sinus and the 
cochlea [14, 30]. Figure 1-8 displays a single axial head CT slice.  
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Figure 1-8: Axial slice view of a head CT scan.  Only one slice of a sequence of slices 
is shown. Image courtesy of 3D Slicer [31, 32] 
CT datasets consist of stacks of multiple two-dimensional (2D) slice images of the same 
specimen. Figure 1-9a represents a stack of axial head CT slices forming a 3D dataset. 
Slice data can be displayed in three-dimensional (3D) environments using medical image 
visualization software such as the open-source 3D Slicer software (www.slicer.org) [31, 
32]. Figure 1-9b demonstrates the 3D rendering of the same dataset.  
In CT, gray level intensities are described by the Hounsfield scale. The values in the scale 
are related to the linear attenuation coefficient of tissues and are expressed in non-
dimensional units, called Hounsfield units (HU) or CT numbers, that are determined by 
the following formula: 
𝐻𝑈 = [
μ𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙−μ𝑤𝑎𝑡𝑒𝑟
μ𝑤𝑎𝑡𝑒𝑟
] × 1000 
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Figure 1-9: Sample head CT scan.  (a) Representation as a stack of 2D slices forming 
a (b) 3D Rendering of the same dataset. Image courtesy of 3D Slicer [31, 32] 
where μ𝑤𝑎𝑡𝑒𝑟 tends to zero and is the linear coefficient of water. Medical grade CT 
scanners are calibrated with water as the reference. Table 1-2 lists HU values for 
common biological materials. The Hounsfield scale is used in image analysis applications 
to locate the boundaries of a material within an image with a known HU number. 
Table 1-2: Reference intensity values in the Hounsfield Scale [33–36] 
Substance HU 
Air -1000 
Lung -600 to -700 
Fat -50 
Water 0 
Blood +13 to +75 
Muscle +50 
Brain 0 to +100 
D4 Bone (Fine 
trabecular bone) 
+150 to +350 
D3 Bone (Porous 
trabecular bone) 
+350 to +850 
D2 Bone (Thick 
porous cortical bone) 
+850 to +1250 
D1 Bone (Dense 
cortical bone) 
>1250 
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1.6.3 Surgical Planning 
For BONEBRIDGE implantation, the patient’s anatomy is analyzed by visualizing the 
bony anatomical structures to determine if it allows for appropriate placement of the 
FMT implant. Specifically, the region of the skull that is selected must be thick enough to 
fully house the implant.  
Manually finding a suitable location is achieved by performing a CT scan of the patient’s 
head and navigating through the axial orientation CT slices to try to find a suitable 
location for the FMT based on the distance to the dura mater (the outer layer of 
membrane protecting the brain). It is essential that during this procedure, the anatomy is 
analyzed to avoid the risk of injury to important anatomical structures, including the 
chorda tympani [37], the sigmoid sinus or the facial nerve [38] during implantation [39]; 
or significant modification of the temporal bone pneumatisation (the air cell1 system) that 
could affect the middle ear pressure buffers [40].  
Manually determining the most suitable location to implant the FMT is time consuming 
and hinders the surgical workflow, which is why surgeons have expressed a need for 
quick and intuitive skull thickness estimation tools. A few attempts have been made to 
develop algorithms to estimate the thickness of the skull from each patient’s CT scan and 
generate a map that can visually guide the surgeon in selecting a location that is thick 
enough to house the implant. 
1.7 Image segmentation 
Segmentation is an image processing technique used to partition a digital image to 
simplify its analysis. Image segmentation is employed in medical imaging to separate 
anatomical structures for visualization and diagnosis. Thresholding is the simplest form 
of segmentation, where an HU number is used as the lower grayscale intensity boundary 
to binarize an image into two values: pixels with HU equal to or above the threshold 
                                                 
1
Air cells in bone are cavities filled by air. Air cells are present in human temporal bones. The air cells 
connect to the middle ear.  
15 
 
represent pixels inside the segmentation (assuming the region of interest is brighter than 
other tissue) and HU values below the threshold are considered outside the segmentation. 
The opposite applies if the threshold is set as an upper boundary (i.e., the tissue of 
interest is darker than the other tissue). Figure 1-10 shows the segmentation result when 
using a lower threshold value of 150 HU, therefore labelling all pixels within the data 
with intensities 150 HU and above as the segmented part. Because the thinner type of 
bone is described as having a CT number of 150 HU, the figure displays the skull within 
the dataset. 
 
Figure 1-10: Segmentation results (BELOW) and 3D model (ABOVE) of sample 
data using 150 HU threshold to segment bone. 
1.8 Literature Review 
To improve on slice-by-slice manual processing to find a suitable implant location, some 
surgeons have reported using volume rendering of the BONEBRIDGE FMT inside CT 
images of the head, and simultaneously navigating through axial slices to determine a 
location with sufficient space to house the implant [14]. A common tool used for this 
approach is the BB FASTVIEW (CEIT, Guipuzcoa, Spain) software. The only guidance 
to find the location for the implant are the anatomical landmarks and the patient’s clinical 
history [14]. This approach does not consider the air cells in the skull which are important 
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for screw placement as described below. Also, processing times have been reported to be 
over an hour long [41]. 
Other approaches overlay color maps on temporal bone models using different colors to 
depict the thickness of the bone from the cortical layer, but with no consideration of the 
air cells of the skull [42, 43]. This is problematic as the inclusion of the air cells in the 
segmentation can lead to over-estimation of the bone thickness, which may result in 
surgical complications if an implant location where there is not enough bone to hold the 
surgical screws is selected. Figure 1-11 represents a fictional case where the 
segmentation would prevent the visualization of the air cells, and the implant (overlaid) 
would be placed in an area without enough thick bone to hold it. Improper placement of 
the implant can result in secretory otitis media, among other complications such as 
cholesteatoma [40]. The software developed for this approach was presented as a C++ 
application with much quicker run rimes than the BB FASTVIEW approach, but it is not 
available to the public for download [42].  
 
Figure 1-11: Representation of an axial slice view of a segmentation where air cells 
are considered bone (LEFT). Example of implant location where there is not enough 
bone to hold the BONEBRIDGE’s surgical screws (RIGHT) 
1.9 Objective 
The main objective of this work was to develop a prototype thickness estimation software 
tool that would consider the air cells in the estimates to produce colored thickness maps 
of the distances from the cortical bone layer to the first air cell and from the cortical layer 
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to the dura mater, therefore aiding in the surgical planning of the BONEBRIDGE FMT, 
as well as the placement of the screws. The second objective was to validate the tool by 
comparing a sample of the algorithm’s thickness estimations to measurements made by a 
surgeon with BONEBRIDGE implantation experience.  
1.10 Hypothesis  
It was hypothesized that bone thickness estimates obtained from both the proposed 
algorithm and expert measurements to air and to dura would not differ significantly from 
each other. 
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Chapter 2  
Development and Validation of a Surgical Planning 
Tool for Bone-Conduction Implants 
 
2.1 Background 
The BONEBRIDGE® (Med-El GmbH, Innsbruck, Austria) is a transcutaneous bone-
conduction device (BCD) intended to treat conductive (CHL) and mixed hearing losses 
(MHL). The device consists of an externally worn audio processor and a subcutaneous 
floating mass transducer (FMT) implant that is surgically anchored to the temporal bone 
[1]. The external component powers the FMT, classifying the BONEBRIDGE as an 
active, semi-implantable BCD [2]. The active nature of the FMT avoids the transfer of 
vibrational energy transcutaneously, thus overcoming the shortcomings of percutaneous 
and passive transcutaneous bone conduction devices [3, 4].  
One disadvantage of the BONEBRIDGE is that the FMT is 8.7mm in height and 15.8mm 
in diameter, therefore surgical planning is required in order to find safe locations for 
implantation. Currently described locations include the mastoid, retrosigmoid, and middle 
fossa areas [5]. In the mastoid, there can often be limited room between the sigmoid 
sinus, tegmen mastoideum2, external auditory canal, and facial nerve to safely house the 
implant. This location is often excluded in patients with chronic otitis media or previous 
mastoidectomies [4]. The retrosigmoid and middle fossa areas are alternatives in these 
cases, however the skull thickness can often preclude complete implantation without 
dural compression and/or the use of BCI lifts [5–9].  In addition, the screws securing the 
implant typically require 3-4 mm of cortical bone thickness for fixation, however in 
                                                 
2
 The thin plate of bone that covers the middle ear. 
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highly pneumatized temporal bones, the cortex adjacent to the air cells can be very thin. 
An implanted BONEBRIDGE is shown in Figure 2-1. 
 
 
Figure 2-1: Cross-section of an implanted BONEBRIDGE bone-conduction device 
[10] 
Current surgical planning techniques use computed tomography (CT) images to perform 
manual thickness measurements [10]. As these are conducted on two dimensional slices, 
the eventual location is difficult to transfer to the patient in the operating room. Some 
research groups such as Zernotti [5] and Weiss et al. [7] have experimented with the BB 
FASTVIEW tool (Center for Technical Studies and Research at the University of 
Navarra, Spain) which allows visualization of the FMT inside CT slices and three-
dimensional (3D) reconstructions. In their work, they described three potential 
implantation sites and their subjective experience with the tool. Kong et al. [11] also used 
BB Fast View combined with image guidance to find potential implantation locations on 
one patient in the operating room. This approach, however, was time consuming with the 
navigation process taking over 90 minutes [11].   
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Plontke [12] proposed a similar planning tool that implemented 3D visualization with 
AMIRA (Thermo Fisher Scientific, Waltham, MA, USA), however this commercial tool 
is costly and not readily available to surgeons for pre-operative planning. This technique 
also required manually moving the virtual implant to determine the optimal location, with 
no automated guidance for the surgeon. 
Treece et al. [13, 14] developed a technique to calculate the cortical thickness in 
cadaveric femurs. This method consisted of thresholding to find an initial approximate 
surface, then fitting the surface to the data by comparing the intensity values on the 
cortical layer. Next, a new surface was interpolated and its vertices and normals were 
used to guide the thickness calculation, which was solved with a generic curve fitting 
algorithm that found the local image minima. This algorithm estimated the cortical 
thickness for each surface vertex, yielding approximately 17,000 thickness estimates per 
sample. Lillie et al. adapted this algorithm to measure cranial vault cortical thickness, 
which was found to be below 4 mm on average in multiple areas of the skull [15, 16].  
Wimmer et al. [17] described a different technique to measure the thickness of the 
temporal bone for the surgical planning of bone-conduction implants. This method 
incorporated thresholding, cropping, manual editing, and then morphological filtering to 
find the inner and outer surfaces of the bone. The thickness was estimated by calculating 
the Euclidean distance (straight-line distance) between their vertices. This generated a 
distance from the cortical bone to the dura, however the air cells were not considered as 
they had been filled via a morphological hole filter. The last iteration of this group’s 
technique, described by Barakchieva et al. [18], was developed using the C++ 
programming language. 
The primary objective of the current study was to develop an open-source, automated 
thickness estimation algorithm for surgical planning of the BONEBRIDGE. This novel 
technique would include the total thickness of the bone for FMT placement, as well as 
consideration of the air cells for placement of the screws.  The secondary objective was to 
validate this algorithm against manual measurements made by an experienced surgeon.  
24 
 
2.2 Methods 
2.2.1 Clinical CT images  
Twelve cadaveric temporal bone CT images were obtained using a Discovery CT750 HD 
Clinical Scanner (GE Healthcare, Chicago, IL). The scanner was set to acquire images at 
a resolution of 234 µm, a slice thickness of 0.625 mm, and an x-ray voltage of 120 kV. 
Ethics approval was obtained through Western University’s Committee for Cadaveric 
Use in Research (approval number #19062014). The data used in the current study are 
available from the corresponding author upon request. 
2.2.2 Algorithm Development 
2.2.2.1 Segmentation 
To prototype the algorithm, the images were first processed using the open source 
software 3D Slicer (www.slicer.org). The region of interest (ROI) contained the entire 
temporal bone, including the mastoid, retrosigmoid, and middle fossa areas.  
Segmentation was then performed utilizing a thresholding filter to separate bone from 
surrounding soft tissues. Depending on the case, dilation was used to add single layers of 
voxels to the nearest eight integers; a connectivity filter was used to remove regions 
smaller than 400 voxels not connected to the enclosed segmentation, and the 
morphological remove islands filter was used to remove regions partly connected to the 
segmentation smaller than 200 voxels. This ensured the final segmentations were closed 
surfaces. Lastly, the resulting closed surfaces were converted into models.  
2.2.2.2 Post-Processing 
The segmented models were exported to Geomagic (3D Systems, Morrisville, North 
Carolina, USA) for smoothing and averaging. This was done to reduce the number of 
triangles in the surface mesh, thereby preventing long computation times. The 
intersections and small components parameters were set to zero in the Mesh Doctor 
function of Geomagic to ensure convergence of the algorithm. The outer surfaces of the 
models were then separated from the rest of the model and used to initialize thickness 
estimation.  
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2.2.2.3 Ray Casting 
A custom program was written in Matlab (MathWorks, Natick, Massachusetts, USA) to 
implement a traversal ray casting algorithm, adopted from Amanatides and Woo [19], on 
the segmented models. The primary parameters of the algorithm were the voxel intensity 
thresholds of the cortical bone, air cells and the dura mater (Figure 2-2). The first two 
thresholds used in this experiment were selected in accordance with the Misch 
classification of bone [20]. The threshold for bone was set to 600 Hounsfield units (HU), 
corresponding to thin cortical bone, and the threshold for air was set to 150 HU, below 
the fine trabecular bone intensity. These parameters were determined during development 
by visualizing the algorithm results on test images. HU values tested for thicknesses to air 
are displayed in Figure 2-3.  
 
 
Figure 2-2: Schematic illustrating the ray casting algorithm to the first air cell and 
to dura 
The program obtained the outer surface model triangulation and used the triangle centers 
as starting points for the thickness estimations. Each ray was cast from the first bone 
voxel in the normal direction of its respective triangle towards the inside of the skull.  
The traversed distance was measured at the intersecting voxels, which were found to be 
below the grey levels in HU set for air and dura. The script was written to inspect 20 
consecutive voxels beyond the voxel where the threshold was reached to ensure that the 
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algorithm had actually found dura, and not a large air cell.  
 
 
Figure 2-3: Thickness color maps from bone to air cells at (A) 400, (B) 150 and (C) 
1000 HU. The units of the colorbar are mm. 
2.2.2.4 Visualization 
The voxels traversed by the rays were converted to distance in millimeters. Two sets of 
thickness estimates per sample were then saved; the first being the thickness from the 
outer surface to the first air cell, and the second being the distance from the outer surface 
to the dura. Two color maps showing these estimates were visually overlaid onto the 
segmented models. The color maps for the distance to the first air cell were specifically 
set from 0 to 4 mm, corresponding to the amount of cortical thickness needed to fully 
embed the screws. The color map to the dura was set from 0 to 9 mm, which corresponds 
to the thickness of the actual FMT (8.7 mm).   
2.2.3 Validation 
To compare the algorithm’s estimations with expert observations, a neurotologist 
experienced in BONEBRIDGE implantation (S.K.A.) performed measurements using a 
set of uniformly distributed points (n=200) laid on the cortical layer of the temporal bone.  
These points were distributed to cover the most common implantation areas in the 
mastoid, retrosigmoid, and middle fossa areas. The expert visualized each point in the 
axial slice view and placed fiducials on the cortical bone, first air cell, and dura as shown 
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in Figure 2-4. The fiducials were converted to a distance in millimeters to correspond to 
the same distances calculated by the algorithm.   
 
 
Figure 2-4: Grid of evenly distributed points laid by the program (A). Expert 
measurements from the cortical bone in reference to the first air cell and to dura (B) 
2.2.3.1 Statistical Analyses  
The data were analyzed using IBM SPSS Statistics (Version 23.0. Armonk, IBM Corp., 
New York USA) and graphed with GraphPad Prism (Version 7.00, GraphPad Software, 
La Jolla California USA). The means, 95% confidence intervals (95% CI), differences, 
and mean absolute differences (MAD) were calculated.  Normality was evaluated using 
skewness, kurtosis, and the Shapiro-Wilk test. The Spearman’s ranked correlation 
coefficient was calculated, and the Wilcoxon signed-rank test was used to determine 
differences between the algorithm and expert measurements. Significance was set to p < 
0.05. Multiple comparisons were controlled using the Holm–Bonferroni method. The 
differences and absolute differences between the algorithm and expert observations were 
then calculated and included in the database. 
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2.3 Results 
2.3.1 Algorithm 
The ray-casting algorithm was successfully implemented and a surgical planning tool was 
developed to be used by surgeons pre-operatively. Each cortical surface consisted of 
approximately 135,000 triangles, and the program was multi-threaded allowing for the 
processing of multiple samples simultaneously. The workstation had a core-i7 (Intel 
Corporation, Santa Clara, CA, USA) processor, 24 GB memory, and an Nvidia GTX 970 
graphics card (Nvidia Corporation, Santa Clara, CA, USA). The total computation time 
was approximately 10 minutes per sample.   
The top part of Figure 2-5 shows a thickness color map of a thick sample bone, where 
most areas except for the most anterior part of the middle fossa can hold the screws. The 
same applies to the FMT, while also avoiding the most inferior part of the mastoid. Areas 
with thinner bone would require dural compression and/or BCI lifts for successful 
implantation. A thinner sample bone is shown in the bottom part of Figure 2-5, where the 
sigmoid sinus is visible in the bone to dura thickness map. In this case, the most 
appropriate location for the FMT and the screws would be in the medial mastoid. The 
tool is meant to suggest potential implantation areas which are to then be confirmed by 
the surgeon.  
29 
 
 
Figure 2-5: Thickness color map from bone to air cell (LEFT) and bone to dura 
(RIGHT).  Sample with thick cortical bone (TOP). Sample with thinner cortical 
bone (BOTTOM). Units in mm. 
 
2.3.2 Validation 
2.3.2.1 Bone to air Cell Measurements 
When comparing all points (n=200), the automated (mean=4.7 mm, CI of 4.3-5.0 mm) 
and expert (mean=4.7 mm, CI of 4.4-5.0 mm) bone to air thickness measurements were 
not significantly different, p=0.36. The MAD was small (0.30 mm, CI of 0.26-0.34 mm). 
The raw data are graphed in Figure 2-6, revealing excellent correlation between the 
algorithm and expert measurements (r=0.98, p>0.001).  
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Figure 2-6: Scatter-plot of measurements from bone to air cell by the algorithm and 
expert. 
An analysis by sub-site is provided in Figure 2-7. In the mastoid area (n=17), the 
automated (mean=4.4 mm, CI of 3.2-5.7 mm) and expert measurements (mean=4.5 mm, 
CI of 3.2-5.8 mm) were not significantly different, p=0.98. Similarly, for the middle fossa 
(n=140), the automated (mean=4.3 mm, CI of 3.9-4.7 mm) and expert (mean=4.3 mm, CI 
of 4.0-4.7 mm) thicknesses were not significantly different, p=0.76. Nonetheless, in the 
retrosigmoid area (n=23), the automated (mean=5.6 mm, CI of 4.5-6.6 mm) thickness 
measurements were statistically smaller than the expert (mean=5.8 mm, CI of 4.9-6.7 
mm) markings, Z = -2.1, p=0.03. In addition, when controlling for family-wise error with 
the Holm-Bonferroni method, all p-values for the subsets of air measurements remained 
above a=0.05 after correction, thereby not rejecting the null hypothesis in any case.   
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Figure 2-7: Box-plot of algorithm and expert measurements to the first air cell.  All 
points, mastoid, middle fossa, and retrosigmoid areas. The star represents 
significant difference, p<0.05 
2.3.2.2 Bone to dura Measurements 
When comparing all points (n=200), the automated (mean=6.0 mm, CI of 5.4-6.5 mm) 
and expert (mean=5.9 mm, CI of 5.4-6.5 mm) bone to dura thickness measurements were 
significantly different, Z = -3.7, p<0.01. The MAD was small (0.31 mm, CI of 0.28-0.35 
mm). The raw data are graphed in Figure 2-8, revealing excellent correlation between the 
algorithm and expert measurements (r=0.99, p>0.001).  
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Figure 2-8: Scatter-plot of measurements from bone to dura by the algorithm and 
expert  
Sub-site results can be observed in Figure 2-9. In the mastoid (n=17), the automated 
(mean=14.5 mm, CI of 11.2-17.7 mm) and expert (mean=14.8 mm, CI of 11.5-18.2 mm) 
measurements were not significantly different, p=0.06. This was also the case in the 
retrosigmoid area (n=23), where the automated (mean=6.1 mm, CI of 5.1-7.1 mm) and 
expert (mean=6.3 mm, CI of 5.4-7.2 mm) measurements were not statistically different, 
p=0.16. However, in the middle fossa (n=140), the automated (mean=4.8 mm, CI of 4.4-
5.2 mm) bone to dura thickness measurements were significantly different than the expert 
(mean=4.6 mm, CI of 4.3-5.0 mm) markings, Z=-5.8, p<0.01. In addition, when 
controlling for family-wise error with the Holm-Bonferroni method, the middle fossa was 
the only subset of dura measurements where the p-values were below a=0.05 after 
correction, being the only area where the null hypothesis was rejected. 
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Figure 2-9: Box-plot of algorithm and expert measurements to the dura.  All points, 
mastoid, middle fossa, and retrosigmoid areas. The star represents significant 
difference, p<0.05 
The differences between the expert and algorithm for bone to air cell and bone to dura 
measurements are shown in Figure 2-10. For bone to air measurements, the MAD values 
by sub-site were 0.37 mm, CI of 0.14-0.60 mm for the mastoid; 0.28 mm, CI of 0.31-0.60 
mm for the middle fossa; and 0.45 mm, CI of 0.23-0.32 mm for the retrosigmoid. The 
MAD for dura measurements were 0.60 mm, CI of 0.4-0.80 mm for the mastoid; 0.26 
mm, CI of 0.23-0.30 mm for the middle fossa; and 0.46 mm, CI of 0.35-0.60 mm for the 
retrosigmoid.  
An overview of the variance within the populations is summarized in Table 2-1, where 
the algorithm, expert and MAD means are displayed along with their respective 95% 
confidence intervals (95% CI). 
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Figure 2-10: Box-plot of algorithm and surgeon differences in millimeters. Positive 
results indicate the algorithm had a larger estimate than the expert. Negative results 
indicate larger measurements by the surgeon 
 
Table 2-1: Mean absolute difference (MAD) results by area with 95% confidence 
intervals. Measurements in millimeters (mm). 
Thickness to Air Cells 
Area Algorithm Expert MAD 
 Mean 95% CI Mean 95% CI Mean 95% CI 
Mastoida  4.4 3.2-5.7 4.5 3.2-5.8 0.37 0.14-0.60 
Middle Fossab 4.3 3.9-4.7 4.3 4.0-4.7 0.28 0.23-0.32 
Retrosigmoidc 5.6 4.5-6.6 5.8 4.9-6.7 0.45 0.31-0.60 
Alld 4.7 4.3-5.0 4.7 4.4-5.0 0.30 0.26-0.34 
Thickness to Dura 
Area Algorithm Expert MAD 
 Mean 95% CI Mean 95% CI Mean 95% CI 
Mastoida  14.5 11.2-17.7 14.8 11.5-18.2 0.60 0.4-0.80 
Middle Fossab 4.8 4.4-5.2 4.6 4.3-5.0 0.26 0.23-0.30 
Retrosigmoidc 6.1 5.1-7.1 6.3 5.4-7.2 0.46 0.35-0.60 
Alld 6.0 5.4-6.5 5.9 5.4-6.5 0.31 0.28-0.35 
a n=17, b n=140, c n=23, d n=200 including 20 points close to implantation sites 
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2.4 Discussion 
Current approaches to the surgical planning of the BONEBRIDGE reported in the 
literature include manual image-guided placement. This approach consists of using CT 
images to visualize an implant model that is manually placed by the surgeon inside 
regions of the CT corresponding to potential placement locations; thickness maps are not 
provided for guidance. Plontke et al. [12] and Cho et al. [21] used commercial software to 
simulate the implant inside the images. Kong et al. [11] used a freely available program, 
BB Fast View (CEIT, Guipuzcoa, Spain), and Todt et al. developed [22] and reviewed 
[23] a similar simulator using open-source software ZIBAMIRA (Zuse Institute Berlin, 
Germany). Law et al. [24] used the program 3D Slicer to visualize the FMT and screws to 
find a suitable implantation location by measuring bone thickness in the skull landmarks. 
In Matsumoto and colleague’s work [25], a surface template guide was also visualized as 
a guide for surgery. Among these studies, Law and colleagues [24] did not consider 
perforating large air cells, whereas most other studies considered air cells as part of the 
bone in their manual estimations. In contrast, Inui et al. [26] presented ray casting as a 
general application to determine thickness and clearance in 3D objects. In the current 
study, a thickness estimation algorithm was prototyped that accounted for the air cells in 
the temporal bone, thereby preventing overestimation of the thicknesses to air and to the 
dura mater.  
The first applied topographical thickness map was presented in Wimmer’s original 
publication [17]. His group used Amira (thermofisher.com/amira-avizo) to process the 
images and lay a color map. Later, Barakchieva et al. [18] presented an approach using 
C++. In the current study, we present a prototype for which the running time of the 
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algorithm per bone was approximatively ten minutes. Our results suggest that with the 
current parameters, this algorithm can aid in the surgical planning of the BONEBRIDGE 
FMT in all three implantation areas.  
Measurements to the dura had statistically significant variation (p<0.01). Despite this, the 
overall MAD was 0.31 mm (CI of 0.28-0.35 mm) which is below the 0.625 mm slice 
thickness, making the magnitude of the variance not clinically relevant. The MAD by 
area was 0.6 mm for the mastoid, 0.26 mm for the retrosigmoid and 0.46 mm for the 
middle fossa; all below the axial resolution of 0.625 mm, therefore confirming acceptable 
variance in clinical CT images. The MAD between air measurements was also below the 
image resolution, being 0.3 mm for all (n=200) measurements. The variance in the dura 
can be attributed to the way it was calculated, being from temporal bone images with no 
actual dura or brain. The algorithm was therefore programmed to find a location where it 
would expect to see the dura, sometimes mistaking large air pockets with the expected 
location of the brain. With full-head images, HU values of the brain areas or dura can be 
inputted within the program’s parameters, along with the original code, to increase the 
overall accuracy of the algorithm.  
Each of the major steps in the image-processing pipeline (segmentation, post-processing 
and ray casting) was implemented in different software packages (3D Slicer, Geomagic 
and a custom MATLAB program, respectively). This adds to the processing time and 
could be made more efficient by developing custom C++ functionality and incorporating 
it into a single 3D Slicer module. The parameters can be further constrained to reduce the 
variation and facilitate the porting of the algorithm to an open-source, downloadable tool. 
A path towards computational efficiency can be found by limiting the number of triangles 
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in the triangulation while maintaining accuracy as in Ramm’s work [23]; his team 
segment the data using a statistical shape model approach that has several limitations, 
which make it unsuitable for thickness estimation.  
Some measurements made by the algorithm were very different from the surgeon’s. 
These outliers were caused by the algorithm calculating the normal directions using the 
triangles from the outer cortical surface in 3D, as opposed to the surgeon performing 
thickness measurements only using the axial orientation, which is typically observed to 
analyze head CT scans but represents 2D data. These points were excluded from the 
statistical analyses since the 3D calculation of the normals would be closer to the actual 
ones. The points that were used in the analyses therefore reflected the program and the 
surgeon measuring the same thicknesses, from very similar angles, while maintaining a 
high sample size for statistical power. 
2.5 Conclusion 
At the prototype stage, our algorithm allowed the visualization of faithful representations 
of the bone to air and bone to dura distances at clinical CT resolution. With further 
automation and porting, it can be developed into a viable surgical planning tool to 
suggest implant locations for the BONEBRIDGE and similar BCDs with submillimeter 
accuracy. It is intended that in its final stage, the algorithm will reduce the amount of pre-
clinical time spent analyzing patient anatomy for these types of implants.  
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Chapter 3  
Conclusions and Future Work 
 
3.1 Contribution 
Software for estimating skull thickness for the surgical placement of bone-conduction 
devices, such as the BONEBRIDGE, was developed and presented in this thesis. The 
software computed the local thickness at discrete locations on the skull and color-mapped 
the estimated thicknesses onto the segmented skull, displaying the measurements on two 
colormaps. One colormap was for thickness estimates obtained as the distance from bone 
to the first air cell, and the other colormap was from bone to dura. The colormaps can be 
used by surgeons to visually locate a region of the skull that is thick enough to house the 
BONEBRIDGE and its screws.  
Previous software reported in the literature included the air cells in the thickness 
calculations, allowing the possibility of overestimation. The software developed in this 
work differs in a surgically important manner, as it presents the results of two thickness 
calculations: a colormap of bone to the air cells and a colormap of bone to the dura. In 
other words, instead of only considering the thickness from the cortical bone to dura, it 
allows computation of thickness from bone to the first encountered air cell as well. This 
is important because the screws of the BONEBRIDGE cannot be secured in pneumatized 
areas of the skull. Moreover, as the screws of the BONEBRIDGE transmit vibrations into 
the skull, they must grasp cortical bone.  
The computation time of the algorithm to calculate and display both colormaps was 
approximatively 10 minutes per temporal bone, which is reasonably short. Previous 
approaches where the implant location was determined by visualizing the FMT within CT 
images ranged from 30 [1] to 90 minutes [2] in manual image navigation time. Other 
colormapping approaches in the literature have comparable running times [3, 4]; 
however, due to the exclusion of the air cells in their estimates, they are more prone to 
over-estimation if ported to a clinical application.  
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The thickness estimates in the current study were validated by comparing to an expert 
with several years of experience implanting the BONEBRIDGE device. Thicknesses 
estimated by the algorithm to air and to dura were very close to the expert measurements, 
suggesting that the software can be used in the surgical workflow to automate thickness 
estimation and aid in finding a location for the BONEBRIDGE on a patient-specific 
basis. This contribution is a step towards implementing decision support for surgical 
planning of the BONEBRIDGE and similar BCDs.   
3.2 Limitations and Future Work 
3.2.1 Additional Testing 
The BONEBRIDGE is a relatively new device and is only used at a limited number of 
hospitals. In London, Ontario, BONEBRIDGE surgeries are only performed by one 
surgeon, who is also trained with respect to image-based planning for BONEBRIDGE 
implantation. Hence, a limitation of this study is that the thickness estimation algorithm 
was only tested with respect to one surgeon. To account for inter-observer variability, 
testing needs to be expanded to include other surgeons, preferably with experience in the 
BONEBRIDGE device as well. This would require coordination among multiple 
hospitals and could result in several collaborative studies. 
3.2.2 Decision Support 
The current version of the program is still at the prototype stage, requiring supplementary 
research and augmentation before its clinical use. A decision support system can be 
developed to display candidate implant locations, with or without the BCI lifts, and 
automatically recommending the safest, simplest surgical route. This system can be 
validated with a user study. Identifying skull landmarks is also important for the transfer 
of the image coordinates to the patient’s skull, therefore future versions of the algorithm 
can implement this function and investigate its accuracy to minimize complications from 
improper implant placement. The algorithm will require an intuitive user interface after 
all additional functions are implemented and validated to provide surgical planning of the 
BONEBRIDGE in the clinic. 
42 
 
 
3.2.3 Porting 
Currently, a user’s manual describes all of the processing steps and software packages 
used. Once validated at multiple institutions, the intent is to make the software publicly 
available for the community to use. The C++ programming environment can be 
employed to port the algorithm into a single application as it works with available image 
processing toolkits such as the Insight Toolkit (https://itk.org)[5]. This would allow for 
the incorporation of the algorithm into a single 3D Slicer module with a dedicated 
graphical user interface for easier use. Multi-threading and GPU processing can also be 
explored to achieve the maximum computing efficiency.  
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